<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00717080</url>
  </required_header>
  <id_info>
    <org_study_id>2PR1210826</org_study_id>
    <nct_id>NCT00717080</nct_id>
  </id_info>
  <brief_title>The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction</brief_title>
  <acronym>ACO</acronym>
  <official_title>Role of Capsular Tension Ring in Anterior Capsular Contraction in Retinitis Pigmentosa Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurolab</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurolab</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Randomized Controlled Trial to study the role of Capsular Tension Ring in patients
      with Retinitis Pigmentosa
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cataract is a common complication in retinitis Pigmentosa (RP) patient especially posterior
      sub capsular cataract. Continuous curvilinear capsulorhexis is the preferred method of
      capsulotomy in cataract surgery. Anterior capsular contraction (ACO) is a unique complication
      following cataract surgery. The rate of which is higher in RP patients due to the weak
      zonules and the increased rate of inflammation. CTR has been proven to reduce the rate of
      contraction.

      Study population includes 40 eyes having RP with cataract. 20 eyes will receive CTR and the
      other 20 would not receive CTR. The percentage of anterior capsular contraction would be
      evaluated using EPCO software.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of anterior capsular contraction</measure>
    <time_frame>1 day, 30 days,90 days,180 days,270days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1 day, 30 days,90 days,180 days,270days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IOL surgery with Capsular Tension Ring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IOL surgery without Capsular Tension Ring</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IOL surgery</intervention_name>
    <description>IOL surgery using capsular tension ring (AURORING)</description>
    <arm_group_label>Arm 1</arm_group_label>
    <other_name>AURORING</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IOL surgery</intervention_name>
    <description>IOL surgery without CTR</description>
    <arm_group_label>Arm 2</arm_group_label>
    <other_name>Phacoemulsification</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 35 to 65 years

          -  Typical retinitis pigmentosa

          -  Reside within a radius of 100kms from Madurai

          -  Patients willing to come for follow up

          -  Patients with nuclear sclerosis grade 2 or 3 or cortical cataract or pscc

        Exclusion Criteria:

          -  Diabetic patients

          -  Traumatic cataract

          -  Uveitis

          -  Glaucoma

          -  Pseudoexfoliation

          -  Myotonic dystrophy

          -  Corneal pathology

          -  Pupil size &lt;6mm

          -  Intra op complications like zonular dialysis,pc rupture

          -  Rhexis not covering iol optic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haripriya Aravind, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aravind Eye Hospital, Madurai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aravind Eye Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625 020</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2008</study_first_submitted>
  <study_first_submitted_qc>July 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2008</study_first_posted>
  <last_update_submitted>January 24, 2012</last_update_submitted>
  <last_update_submitted_qc>January 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Retinitis Pigmentosa</keyword>
  <keyword>Cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Cone-Rod Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

